SOURCE: Sunwin International Neutraceuticals, Inc.

January 09, 2007 08:30 ET

Sunwin International Neutraceuticals Doubles Stevia Production Capacity With Completion of New Manufacturing Facilities

QUFU, CHINA -- (MARKET WIRE) -- January 9, 2007 -- Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world's leading producers of all natural, zero calorie Stevia in China, announced today that it has completed construction of its new Stevia manufacturing facilities. The new Stevia manufacturing facilities are capable of producing an additional 300 tons of premium Stevia per year, increasing annual bulk production by approximately $15 million per year.

The new facilities will use proprietary technology developed by Sunwin to process the seed of the Stevia rebaudiana plant, enabling the company to produce the highest grade Stevia in the industry. Management believes the premium Stevia produced at the company's new plant will be far superior in taste and quality than any other Stevia on the market. Management believes its proprietary Stevia will provide consumers with the real sugar experience, without the sometimes-bitter aftertaste associated with other competitors' products. The company anticipates that this additional production will be marketed to the pharmaceutical industry in China, Japan, South Korea, and other Far East countries such as Singapore, Malaysia, Thailand, and India to name a few. In addition, the new facilities will be geared for ramping Stevia supplies in support of Sunwin's new product offerings, marketed under the trademark name "Only Sweet" in North America, scheduled to be launched in the first quarter of 2007.

Laiwang Zhang, President and Chairman of Sunwin International Neutraceuticals, commented, "We are very pleased with the completion of the construction of our new plant. We expect to commence with production in the first quarter of 2007 upon completion of the necessary trial runs. We expect the new facility will generate approximately $15 million in annual sales in bulk form at full capacity. This new facility is strategically important for us to enhance our leading position in the production of Stevia worldwide. It will give us substantial leverage in our efforts to consolidate the Stevia production industry in China. We believe our all natural, zero calories Stevia will become a mainstay sweetener as demand for all natural, zero calorie sweeteners has increased dramatically in the past decade worldwide. We are well positioned to be the leading producer in this rapidly growing industry."

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals (OTCBB: SUWN) engages in the areas of essential traditional Chinese medicine, zero calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. For more info about Sunwin, please visit

Safe Harbor Statement

Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Reported results should not be considered as an indication of future performance. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contact Information


    Steven Silbert
    Executive Vice President
    Tel: 954.724.2944